PAR-25-103 - Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 4
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Addressing Cancer-Related Financial Hardship to Improve Patient Outcomes | NOT-CA-25-035 | NCI | Jan 17, 2025 | Jan 8, 2028 | U34, R34, R03, R01, R21, P01 |
Notice of Special Interest (NOSI): Research on rare cancers across the cancer control continuum | NOT-CA-25-010 | NCI | Dec 30, 2024 | Jan 8, 2028 | R01, R03, R21, U34, R34, P01 |
Notice of Special Interest (NOSI): Survivorship Research for People Living with Advanced and Metastatic Cancers | NOT-CA-25-024 | NCI | Dec 17, 2024 | Jan 8, 2028 | U34, R34, R01, R03, R21, P01 |
Notice of Special Interest (NOSI): Factors impacting how Time-Restricted Eating (TRE) influences cancer-related outcomes | NOT-CA-24-073 | NCI | Jul 9, 2024 | May 8, 2027 | R01, U34, K22, R21, K99/R00, K08, R34 |
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|